U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.80G>A (p.Cys27Tyr) AND Familial hypercholesterolemia

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 19, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002580826.3

Allele description [Variation Report for NM_000527.5(LDLR):c.80G>A (p.Cys27Tyr)]

NM_000527.5(LDLR):c.80G>A (p.Cys27Tyr)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.80G>A (p.Cys27Tyr)
HGVS:
  • NC_000019.10:g.11100235G>A
  • NG_009060.1:g.15855G>A
  • NM_000527.5:c.80G>AMANE SELECT
  • NM_001195798.2:c.80G>A
  • NM_001195799.2:c.80G>A
  • NM_001195800.2:c.80G>A
  • NM_001195803.2:c.80G>A
  • NM_001406861.1:c.338G>A
  • NP_000518.1:p.Cys27Tyr
  • NP_000518.1:p.Cys27Tyr
  • NP_001182727.1:p.Cys27Tyr
  • NP_001182728.1:p.Cys27Tyr
  • NP_001182729.1:p.Cys27Tyr
  • NP_001182732.1:p.Cys27Tyr
  • NP_001393790.1:p.Cys113Tyr
  • LRG_274t1:c.80G>A
  • LRG_274:g.15855G>A
  • LRG_274p1:p.Cys27Tyr
  • NC_000019.9:g.11210911G>A
  • NM_000527.4:c.80G>A
Protein change:
C113Y
Molecular consequence:
  • NM_000527.5:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.80G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406861.1:c.338G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002942448Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 19, 2022)
germlineclinical testing

PubMed (10)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.

Wang J, Huff E, Janecka L, Hegele RA.

Hum Mutat. 2001 Oct;18(4):359.

PubMed [citation]
PMID:
11668627

Molecular characterization of familial hypercholesterolemia in German and Greek patients.

Dedoussis GV, Genschel J, Bochow B, Pitsavos C, Skoumas J, Prassa M, Lkhagvasuren S, Toutouzas P, Vogt A, Kassner U, Thomas HP, Schmidt H.

Hum Mutat. 2004 Mar;23(3):285-6.

PubMed [citation]
PMID:
14974088
See all PubMed Citations (10)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002942448.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Cys27 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11668627, 14974088, 19026292, 25463123, 27497240). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant affects a cysteine residue located within an LDLRA or epidermal-growth-factor (EGF)-like domains of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 7548065, 7603991, 7979249). In addition, missense substitutions within the LDLRA and EGF-like domains affecting cysteine residues are overrepresented among patients with hypercholesterolemia (PMID: 18325082). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with LDLR-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 27 of the LDLR protein (p.Cys27Tyr).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024